Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  West Pharmaceutical Services Inc.    WST

WEST PHARMACEUTICAL SERVICES INC. (WST)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Sales1 4001 5091 5991 7241 8622 059
EBITDA280315337378432513
Operating profit (EBIT)190224240275322398
Pre-Tax Profit (EBT)------
Net income95,6144151215249326
P/E ratio46,344,449,631,327,421,4
EPS ( $ )1,301,911,992,903,334,25
Dividend per Share ( $ )0,460,500,540,570,610,67
Yield0,76%0,59%0,55%0,63%0,67%0,73%
Reference price ( $ )60.2284.8398.6791.0291.0291.02
Announcement Date02/18/2016
12:00pm
02/16/2017
12:17pm
02/15/2018
06:52pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Debt-25,6----
Finance--38,9295524733
Operating income (EBITDA)280315337378432513
Leverage
(Debt/EBITDA)
-0,08x----
Capital Expenditure132170131165150150
Book Value Per Share (BVPS)14,2 $15,3 $17,3 $19,6 $22,8 $26,7 $
Cash Flow per Share2,88 $2,93 $3,47 $4,22 $4,81 $5,77 $
Announcement Date02/18/2016
12:00pm
02/16/2017
12:17pm
02/15/2018
06:52pm
---
Balance Sheet Analysis
Assessed data source :
© 2018 Thomson Reuters
Financial Ratios

Size 2018e 2019e
Capitalization 6 731 M$ -
Entreprise Value (EV) 6 436 M$ 6 207 M$
Valuation 2018e 2019e
P/E ratio (Price / EPS) 31,3x 27,4x
Capitalization / Revenue 3,91x 3,62x
EV / Revenue 3,73x 3,33x
EV / EBITDA 17,0x 14,4x
Yield (DPS / Price) 0,63% 0,67%
Price to book (Price / BVPS) 4,65x 4,00x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 15,9% 17,3%
operating Leverage (Delta EBIT / Delta Sales) 1,86x 2,15x
Net Margin (Net Profit / Revenue) 12,5% 13,4%
ROA (Net Profit / Asset) 10,5% 11,4%
ROE (Net Profit / Equities) 15,4% 15,5%
Rate of Dividend 19,6% 18,4%
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   9,57% 8,06%
Cash Flow / Sales 18,1% 19,1%
Capital Intensity (Assets / Sales) 1,19x 1,17x
Financial Leverage (Net Debt / EBITDA) -0,78x -1,21x
EPS & Dividend